Sad indeed. However, even if FDA approves all obesity pills under review, the fact remains majority obese people remain obese even if they lost 5-10% of their body weight.
Which is why the reward side of the risk/reward balance is so bad and why the FDA won't approve one of these that isn't genetically targeted or restricted to 1/8 of an inch of its life via REMS.
Unless otherwise indicated, this is the personal viewpoint of David Miller and not necessarily that of Biotech Stock Research, LLC. We're on Twitter at BiotechStockRsr